I know NVS got a complete response letter from FDA last October. Apparently FDA wanted additional information on dosing. Anyone know the status of NVS' response or how long might be anticipated to respond.
I know the drug was approved in the EU but I can't tell whether additional trials were necessary in the US or just re-analysis of existing data.